Drug Discovery World
MAY 6, 2024
During the period 2016-2021, the Brazilian, Chinese and Indian markets grew by 11.7%, 6.7% In January 2024, he was one of 10 recipients to receive a 2024 European Molecular Biology Organisation (EMBO) Laboratory Installation Grant to support his work developing reliable and predictable gene editing tools. for the US market 2.
PLOS: DNA Science
AUGUST 22, 2024
The tale opens at the Hilo Botanical Gardens in 2016. And there the herbicide sat, until in 2016, workers attempting to repackage and seal the material instead caused a leak. TMV is a common pathogen used in early molecular biology research. Newbie chief plant biologist Rachel Sherrill (named for Crichton’s wife?)
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Target Review
AUGUST 29, 2024
He holds multiple utility and design patents for scientific technologies and has authored various peer-reviewed manuscripts in the fields of bacteriology, virology, immunology, molecular biology, and cancer immunotherapy.
The Pharma Data
FEBRUARY 22, 2021
Born in 1970, the British and American research scientist has been Director of the Department of Microbiome Research at the Max Planck Institute for Developmental Biology in Tübingen since 2016. Before, she was associate professor at Cornell University in the Department of Molecular Biology and Genetics.
Broad Institute
APRIL 25, 2024
Christian Happi Christian Happi However, in other parts of West Africa , Ebola was spreading, infecting nearly 29,000 people and killing more than 11,000 before the outbreak was contained in 2016. These are people on the frontlines,” Happi said. We’re empowering them to be more effective at the job they do on a daily basis.”
The Pharma Data
NOVEMBER 19, 2020
The program is being led by Sosei Heptares and progressed in collaboration with multiple companies including Syngene International, Domainex, Fidelta, o2h Discovery, Piramal, WuXi AppTec and the MRC Laboratory of Molecular Biology. 2016), 59, 6595-6628. References. Hilgenfeld, Febs J. 2014), 281, 4085-4096. Pillaiyar, et al, J.
Drug Discovery World
JULY 25, 2022
Idlir Liko – Director of Technology and co-Founder at OMass Therapeutics – co-founded OMass Therapeutics in 2016 with his DPhil supervisor, Prof. Volume 23 – Issue 3, Summer 2022. About the authors. Dame Carol Robinson and has played a key role in transferring the native Mass Spec technology from academia to OMass.
Expert insights. Personalized for you.
147 
Let's personalize your content